Lifespan Vision Ventures
2 rounds tracked since 8 January 2026.
- Rounds
- 2
- Led
- 1
- Capital in these rounds
- $16.2M
Sectors
Countries
Rounds
- Sift BiosciencesLeadAI-driven peptide immunotherapies that activate memory T cells against cancer $3.7MPre-Seed · 18 Feb
- TECregenBiologics to regenerate the thymus and restore T-cell immunity $12.5MSeed · 8 Jan
No round matches these filters.